Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Blade Therapeutics Raises $45M Series B Financing With Unparalleled Syndicate Of VCs And Strategic Pharma Investors

by vcaonline.com posted 2years ago 843 views
<span style="line-height: 20.8px;">Blade Therapeutics, a private biopharmaceutical company revolutionizing the treatment of fibrotic disease, today announced the closing of a Series B financing led by Deerfield Management, that will bring $45 million into the company when all milestones are completed.&nbsp;</span>

In this article